Skip to main content

Table 1 Functional characterization of MIAT in diseases

From: Long non-coding RNA MIAT in development and disease: a new player in an old game

Disease type

Expression

Function

Related gene

Tissue

Animal

Role

Ref

Myocardial infarction

Up

Proliferation

miR-24/Furin/TGF-β1

Cardiac

Mouse

Pathogenesis

18, 31, 32

Schizophrenia

Down

Differention, maintenance

QKI/SRSF1/DISC1/ERBB4/DRD2/GRM3

Brain

Mouse

Pathogenesis

40–42

Ischemic stroke

Up

N.D.

N.D.

Blood

N.D.

Pathogenesis

37

Diabetic cardiomyopathy

Up

Apoptosis

miR-22-3p/DAPK2

Cardiac

Rat

Pathogenesis

56

Diabetic nephropathy

Down

Viability

Nrf2

Kidney

Rat

Pathogenesis

57

Cataract

Up

Proliferation, apoptosis

Migration

miR-150-5p/Akt

Eye

N.D.

Pathogenesis

58

Bone disease

Down

Migration

N.D.

Adipose

N.D.

Pathogenesis

59

Chronic chagas disease cardiomyopathy

Up

N.D.

N.D.

Heart

Mouse

Pathogenesis

60

Chronic lymphocytic leukemia

Up

Proliferation

Apoptosis

OCT4

Blood

N.D.

Pathogenesis

61

Neuroendocrine prostate cancer

Up

N.D.

N.D.

Prostate

N.D.

Oncogenic

47

Non-small-cell lung cancer

Up

Invasion

miR-150/ZEB1

Lung

N.D.

Oncogenic

52

  1. Abbreviation: N.D. Not determined, TGF-β1 transforming growth factor β1, QKI quaking homolog, DISC1 disrupted in schizophrenia 1, ERBB4 v-erb-a erythroblastic leukemia viral oncogene homolog 4, DAPK2 Death Associated Protein Kinase 2